Practical articles for healthcare providers on peptide therapy, program design, regulatory considerations, and clinical applications. Written for the providers who actually run the programs.
Oral dissolving peptide strips are not GLP-1 medications. The compliant, evidence-aware way to handle the peptide question in a practice running GLP-1 programs, and where strips do and do not fit.
Read article →What the human research supports for collagen, BPC-157, and growth hormone secretagogues in athletic recovery, where the evidence is still preclinical, and the anti-doping line providers must know.
Read article →The provider conversation framework that keeps peptide patient discussions accurate, useful, and compliant. Four framing shifts, a side-by-side script, and the documentation habit that protects the practice.
Read article →A practical, compliance-conscious framework for a peptide intake and consult workflow: the steps, documentation, and conversation structure that keep a program accurate and defensible.
Read article →How sublingual and buccal peptide delivery compares to injection for absorption, what the published research supports, and where the data is still limited.
Read article →How to answer common patient peptide-safety questions accurately, what the research does and does not establish, and how to stay compliant.
Read article →The compliance, education, and follow-up gaps that kill most peptide programs in their first six months, and the structural fix for each.
Read article →The anatomy and mechanism behind sublingual and buccal delivery, why it bypasses first-pass metabolism, and the formulation factors the research identifies.
Read article →How collagen peptides and signal peptides differ in mechanism, what the research describes about each, and how to explain them accurately to patients.
Read article →The peptide formulations with the highest patient demand, the cleanest clinical use cases, and the strongest re-order economics for wellness practices.
Read article →What the published research describes about growth hormone-releasing pathways, slow-wave sleep, and recovery, and where the evidence stops. A clinical reference for providers.
Read article →What the published research describes about NAD+ metabolism, cellular energy, and aging, and where the human evidence stands. A clinical reference for providers.
Read article →The peptide protocols, patient conversation flows, and program economics that work inside chiropractic practices. A practical guide for DCs.
Read article →What the published literature describes about BPC-157 mechanisms, where the evidence is strong, and where it remains preclinical. A clinical reference for providers.
Read article →How aesthetic practices integrate oral dissolving peptide therapy into existing service menus, with the formulations, pricing structures, and patient conversations that work.
Read article →The inventory framework for stocking peptides without tying up cash, running out at peak demand, or letting product sit past optimum freshness.
Read article →The regulatory and operational realities of oral dissolving peptide therapy compared to injectable programs, and which practice types qualify for which products.
Read article →The comparison between NAD+ delivered as oral dissolving strips versus IV infusion. Bioavailability, cost, patient experience, and operational complexity.
Read article →The clinical and operational comparison between BPC-157 delivered as an oral dissolving strip versus a compounded injectable, including bioavailability and adherence data.
Read article →What the published research says about GHK-Cu copper peptide for collagen synthesis, skin rejuvenation, and wound healing. A clinical reference for providers.
Read article →The science behind sublingual peptide delivery, why bioavailability for buccal absorption rivals injection, and how this changes peptide therapy access for clinics.
Read article →